DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "United States Contrast Media Injectors Market Outlook to 2022" report to their offering.
The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Angiographic Injectors, Computed Tomography (CT) Injectors and Magnetic Resonance Imaging (MRI) Injectors.
The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Contrast Media Injectors market segements - Angiographic Injectors, Computed Tomography (CT) Injectors and Magnetic Resonance Imaging (MRI) Injectors.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the United States Contrast Media Injectors market.
- Key players covered include Bayer HealthCare AG, Bracco Imaging S.p.A. and Others.
Key Topics Covered:
1. List of Tables and Figures
2 Introduction
3 Contrast Media Injectors Market, United States
3.1 Revenue ($m), 2008-2015
3.2 Revenue ($m), 2015-2022
3.3 Volume (Units), 2008-2015
3.4 Volume (Units), 2015-2022
3.5 Average Price ($), 2008-2022
3.6 Distribution Share by Revenue ($m), 2014-2015
3.7 Company Share by Revenue ($m), 2015
4 Overview of Key Companies in United States, Contrast Media Injectors Market
5 Contrast Media Injectors Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Jul 26, 2016: Merit Medical Announces Appointment of New Director
6.2 Financial Announcements
6.2.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%)
6.2.2 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016
6.2.3 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
6.2.4 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%)
6.3 Strategy And Business Planning
6.3.1 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation
7 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/v3xj3b/united_states
